Paper
13 June 1989 Blood Flow Changes In Transplantable Urothelial Tumors Treated With The Metallopurpurin, SnET2 And Light.
Steven H. Selman, Binsheng Qin, Harold R. James, Rick W. Keck, Greta M. Garbo, Alan R. Morgan
Author Affiliations +
Proceedings Volume 1065, Photodynamic Therapy: Mechanisms; (1989) https://doi.org/10.1117/12.978001
Event: OE/LASE '89, 1989, Los Angeles, CA, United States
Abstract
Changes in blood flow to transplantable bladder tumors growing in Fischer rats were measured after photodynamic therapy with the photosensitizer tin (II) etiopurpurin dichloride (SnET2) using the radioactive microsphere technique. As with the other photosensitizers, hematoporphyrin derivative and chloroaluminum tetrasulfophthalocyanine, SnET2 and light caused a rapid decrease in tumor blood flow. This occurred when the vehicle for photosensitizer delivery was either an emulsion or a liposome. Systemic heparinization of animals did not alter changes in tumor blood flow.
© (1989) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Steven H. Selman, Binsheng Qin, Harold R. James, Rick W. Keck, Greta M. Garbo, and Alan R. Morgan "Blood Flow Changes In Transplantable Urothelial Tumors Treated With The Metallopurpurin, SnET2 And Light.", Proc. SPIE 1065, Photodynamic Therapy: Mechanisms, (13 June 1989); https://doi.org/10.1117/12.978001
Lens.org Logo
CITATIONS
Cited by 1 scholarly publication.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Blood circulation

Photodynamic therapy

Electroluminescence

Phototherapy

Arteries

Light sources

Back to Top